How many institutions own IMUC stock?

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own IMUC shares is 0, representing N/A of the company's common stock.

Who are the major shareholders selling ImmunoCellular Therapeutics, Ltd. stock?

UBS GROUP AG, in the last quarter, reduced its stake in IMUC by -100% restricting it's holding to 0 shares of worth nearly -. REHMANN CAPITAL ADVISORY GROUP also lessened -100% of the IMUC shares from its portfolio, reducing its holding to 0 shares of worth -. NEXT FINANCIAL GROUP, INC also shunned IMUC shares holding by -100% last quarter which brought its holding to 0 shares worth -.

Investors who are buying IMUC stock?

As per its latest 13F filing, CAPTRUST FINANCIAL ADVISORS increased its stake in IMUC by 100% in the last quarter. The institutional holder raised its holding to 25 shares having worth more than -. IFP ADVISORS, INC also added 100% more shares of IMUC to its portfolio, raising its holding to 95 shares of worth -. WEDBUSH SECURITIES INC also increased its IMUC shares holding by 219.58% which brought its holding to 276.53 thousand shares worth $5.00K.

IMUC's major insiders: who are they?

The insider with the most stakes in IMUC is Gengos Andrew , President and CEO at the company. Additionally, IMUC stock is highly held by Senior VP Strategic Resources Gringeri Anthony and VP of Finance FRACTOR DAVID among others.

Did an insider recently sell IMUC stock?

Company executives, directors, and other insiders own 94.97% percent of ImmunoCellular Therapeutics, Ltd.'s stock. Within the last six months, there have been 0 transaction(s) in which IMUC insiders have sold stock, totaling 0 shares. Insiders that have sold shares include COWELL RICHARD, YU JOHN S, and BENDER JAMES G..

Which insider recently purchased IMUC stock?

There have been 0 transaction(s) during the past 6-months in which ImmunoCellular Therapeutics, Ltd. insiders have bought stock, totalling 0 shares

How much of IMUC does insiders own?

Around 0 ImmunoCellular Therapeutics, Ltd. shares are held by insiders, which represents about 94.97% of IMUC stock.

Who is the insider with the largest stake?

IMUC President and CEO, Gengos Andrew holds the largest portfolio of the company's shares. IMUC shares owned by Gengos total nearly 47 thousand.

Which institution holds the most shares in IMUC?

CAPTRUST FINANCIAL ADVISORS is the largest institutional owner in IMUC which holds 25 shares worth - or 0% of the total IMUC shares outstanding followed by UBS GROUP AG with ownership of 0 shares representing 0% of the IMUC ownership. REHMANN CAPITAL ADVISORY GROUP is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.

Is ImmunoCellular Therapeutics, Ltd. stock optionable?

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the IMUC is concerned, it is a stock which is not optionable.

Is there a short position on IMUC's shares?

Number of IMUC shares short is 165.95K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

About how many outstanding IMUC shares are there?

As of today, 126.50M shares of IMUC are outstanding.

Is there many float in IMUC stock?

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, IMUC has 5.70M shares in float.

IMUC short ratio: what is it?

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for IMUC is 4.13.

ImmunoCellular Therapeutics (IMUC) insider trading activity: Get Latest News Today

Stock Outstanding Shares

Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.

ShortableNo

OptionableNo

Short Percent Of Outstanding Shares3.96

Short Percent Of Float3.96

Shares Outstanding126.50M

Shares Float5.70M

Shares Short165.95K

Short Ratio4.13

3.96%

Short % of Float

3.96%

Short % of Shares Outstanding

Market Insider

Investors cannot turn a blind eye to insiders as well as institutional ownership. They need to follow insider trades to determine the direction the stock is likely to take.

Major Holders Summary

94.97% Percentage of Shares held by All Insiders

N/A Percentage of Shares held by All Institutions

N/A Percentage of Float held by Institutions

Number of Institutions Holding Shares

Institutional Ownership

About N/A of IMUC shares are held by financial institutions. CAPTRUST FINANCIAL ADVISORS is the top corporate investor, holding 25 shares valued at -. A 0% stake in ImmunoCellular Therapeutics, Ltd. is owned by the company. UBS GROUP AG owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Jun 30, 2020	CAPTRUST FINANCIAL ADVISORS	0%	25	-	25	+100.00%
Dec 31, 2018	UBS GROUP AG	0%	0	-	-58.54K	-100.00%
Dec 31, 2018	REHMANN CAPITAL ADVISORY GROUP	0%	0	-	-69	-100.00%
Dec 31, 2018	NEXT FINANCIAL GROUP, INC	0%	0	-	-3K	-100.00%
Dec 31, 2018	VANGUARD GROUP INC	0%	0	-	-285.15K	-100.00%
Dec 31, 2018	IFP ADVISORS, INC	0%	95	-	95	+100.00%
Dec 31, 2018	ANCORA ADVISORS, LLC	0%	0	-	-50	-100.00%
Dec 31, 2018	INVESCO LTD.	0%	0	-	-10.99K	-100.00%
Dec 31, 2018	FINANCIAL ARCHITECTS, INC	0%	0	-	-1	-100.00%
Dec 31, 2018	CITADEL ADVISORS LLC	0%	0	-	-69.75K	-100.00%
Dec 31, 2018	SUSQUEHANNA INTERNATIONAL GROUP, LLP	0%	0	-	-32.87K	-100.00%
Dec 31, 2018	TWO SIGMA SECURITIES, LLC	0%	0	-	-61.45K	-100.00%
Dec 31, 2018	VIRTU FINANCIAL LLC	0%	0	-	-71.03K	-100.00%
Dec 31, 2018	WEDBUSH SECURITIES INC	0.02%	276.53K	5K	190K	+219.58%
Dec 31, 2018	BARCLAYS PLC	0%	0	-	-50	-100.00%
Dec 31, 2018	MORGAN STANLEY	0%	0	-	-113	-100.00%
Dec 31, 2018	AVANTAX PLANNING PARTNERS, INC.	0%	0	-	-74	-100.00%
Dec 31, 2018	JACOBI CAPITAL MANAGEMENT LLC	0%	0	-	-125	-100.00%
Dec 31, 2018	WELLS FARGO & COMPANY/MN	0%	0	-	-250	-100.00%
Dec 31, 2018	FIRST ALLIED ADVISORY SERVICES, INC.	0%	0	-	-40K	-100.00%
Dec 31, 2018	STEWARD PARTNERS INVESTMENT ADVISORY, LLC	0%	0	-	-125	-100.00%
Dec 31, 2018	RENAISSANCE TECHNOLOGIES LLC	0%	0	-	-1.21M	-100.00%
Dec 31, 2018	BLACKROCK INC.	0%	0	-	-672	-100.00%
Dec 31, 2018	TRADEWINDS CAPITAL MANAGEMENT, LLC	0%	0	-	-200	-100.00%
Dec 31, 2018	CERTIFIED ADVISORY CORP	0%	20	-	0	0
Dec 31, 2018	AMERICAN PORTFOLIOS ADVISORS	0%	0	-	-5	-100.00%

Insiders

Among the IMUC insiders holding of 94.97% of the stake in company, GENGOS ANDREW, President and CEO, holds the largest shares of 47K. GRINGERI ANTHONY, Senior VP Strategic Resources, is the second largest IMUC insider with ownership of 21K shares. FRACTOR DAVID, VP of Finance, stands third with possession of 11.67K shares of that stake.

Insiders	Designation	Shares Held
GENGOS ANDREW	President and CEO	47K
GRINGERI ANTHONY	Senior VP Strategic Resources	21K
FRACTOR DAVID	VP of Finance	11.67K
COWELL RICHARD	director	10K
BENDER JAMES G.	VP, Product Development & Mfg.	100
TITUS GARY	director	100
YU JOHN S	Secretary	0

Buying/Selling by Insiders

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Nov 30, 2015	GENGOS ANDREW	PURCHASE	0.43	10K	4.35K	47K
Feb 18, 2015	GRINGERI ANTHONY	PURCHASE	0.66	21K	13.86K	21K
Feb 18, 2015	GENGOS ANDREW	PURCHASE	0.66	28.93K	19.1K	28.93K
Feb 18, 2015	FRACTOR DAVID	PURCHASE	0.66	11.67K	7.7K	11.67K
Aug 21, 2014	GRINGERI ANTHONY	PURCHASE	0.91	11K	10.01K	36K
Aug 14, 2014	GENGOS ANDREW	PURCHASE	0.90	10K	8.99K	37K
Dec 23, 2013	GRINGERI ANTHONY	PURCHASE	0.87	25K	21.64K	25K
Dec 20, 2013	TITUS GARY	PURCHASE	0.78	100	77.99	100
Dec 18, 2013	GENGOS ANDREW	PURCHASE	0.72	27K	19.36K	27K
Nov 26, 2013	COWELL RICHARD	SALE	3.86	8.3K	32.03K	10K
Nov 25, 2013	COWELL RICHARD	SALE	3.50	30.3K	106.1K	10K
Oct 21, 2013	YU JOHN S	SALE	2.92	36.01K	105.08K	0
Oct 18, 2013	YU JOHN S	SALE	2.91	231.38K	673.23K	0
Aug 29, 2013	BENDER JAMES G.	SALE	3.00	900	2.7K	100
Aug 28, 2013	BENDER JAMES G.	SALE	2.88	5K	14.4K	1K
Jun 01, 2012	BENDER JAMES G.	SALE	3.61	600	2.17K	879
May 31, 2012	BENDER JAMES G.	SALE	3.94	200	788	7.68K

IMUC Stock Ownership Breakdown

EOM Pharmaceuticals

Stock Outstanding Shares

Market Insider

Institutional Ownership

Insiders

Buying/Selling by Insiders

Frequently Asked Questions

Stock Outstanding Shares

Market Insider

Institutional Ownership

Insiders

Buying/Selling by Insiders

Frequently Asked Questions